193 related articles for article (PubMed ID: 38075203)
1. Multi-omics approach for identifying CNV-associated lncRNA signatures with prognostic value in prostate cancer.
Tyagi N; Roy S; Vengadesan K; Gupta D
Noncoding RNA Res; 2024 Mar; 9(1):66-75. PubMed ID: 38075203
[TBL] [Abstract][Full Text] [Related]
2. Eight-lncRNA signature of cervical cancer were identified by integrating DNA methylation, copy number variation and transcriptome data.
Zhong Q; Lu M; Yuan W; Cui Y; Ouyang H; Fan Y; Wang Z; Wu C; Qiao J; Hang J
J Transl Med; 2021 Feb; 19(1):58. PubMed ID: 33557879
[TBL] [Abstract][Full Text] [Related]
3. Integrative analysis of prognostic long non-coding RNAs with copy number variation in bladder cancer.
Zhong W; Wang D; Yao B; Chen X; Wang Z; Qu H; Ma B; Ye L; Qiu J
J Zhejiang Univ Sci B; 2021 Aug; 22(8):664-681. PubMed ID: 34414701
[TBL] [Abstract][Full Text] [Related]
4. Genome-wide transcriptomics and copy number profiling identify patient-specific CNV-lncRNA-mRNA regulatory triplets in colorectal cancer.
Liu T; Liu Y; Su X; Peng L; Chen J; Xing P; Qiao X; Wang Z; Di J; Zhao M; Jiang B; Qu H
Comput Biol Med; 2023 Feb; 153():106545. PubMed ID: 36646024
[TBL] [Abstract][Full Text] [Related]
5. Multi-Omics analysis identifies a lncRNA-related prognostic signature to predict bladder cancer recurrence.
Xu Z; Chen H; Sun J; Mao W; Chen S; Chen M
Bioengineered; 2021 Dec; 12(2):11108-11125. PubMed ID: 34738881
[TBL] [Abstract][Full Text] [Related]
6. Identifying enhancer-driven subtype-specific prognostic markers in breast cancer based on multi-omics data.
Zhao H; Zhang S; Yin X; Zhang C; Wang L; Liu K; Xu H; Liu W; Bo L; Lin S; Feng K; Lin L; Fei M; Ning S; Wang L
Front Immunol; 2022; 13():990143. PubMed ID: 36304471
[TBL] [Abstract][Full Text] [Related]
7. Identification three LncRNA prognostic signature of ovarian cancer based on genome-wide copy number variation.
Zheng M; Hu Y; Gou R; Nie X; Li X; Liu J; Lin B
Biomed Pharmacother; 2020 Apr; 124():109810. PubMed ID: 32000042
[TBL] [Abstract][Full Text] [Related]
8. Selection of lncRNAs That Influence the Prognosis of Osteosarcoma Based on Copy Number Variation Data.
Zhang J; Huang C; Zhu G; He G; Xu W; Li J; Wang D; Han K; Shen Z; Liu J
J Oncol; 2022; 2022():8024979. PubMed ID: 35378771
[TBL] [Abstract][Full Text] [Related]
9. Identification of Three Prognosis-Related Differentially Expressed lncRNAs Driven by Copy Number Variation in Thyroid Cancer.
Tian J; Luo B
J Immunol Res; 2022; 2022():9203796. PubMed ID: 35642209
[TBL] [Abstract][Full Text] [Related]
10. Identification and Validation of Six Autophagy-related Long Non-coding RNAs as Prognostic Signature in Colorectal Cancer.
Cheng L; Han T; Zhang Z; Yi P; Zhang C; Zhang S; Peng W
Int J Med Sci; 2021; 18(1):88-98. PubMed ID: 33390777
[TBL] [Abstract][Full Text] [Related]
11. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K
World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911
[TBL] [Abstract][Full Text] [Related]
12. Identification of a novel defined inflammation-related long noncoding RNA signature contributes to predicting prognosis and distinction between the cold and hot tumors in bladder cancer.
Xiong X; Chen C; Li X; Yang J; Zhang W; Wang X; Zhang H; Peng M; Li L; Luo P
Front Oncol; 2023; 13():972558. PubMed ID: 37064115
[TBL] [Abstract][Full Text] [Related]
13. Identification and comprehensive characterization of lncRNAs with copy number variations and their driving transcriptional perturbed subpathways reveal functional significance for cancer.
Xu Y; Wu T; Li F; Dong Q; Wang J; Shang D; Xu Y; Zhang C; Dou Y; Hu C; Yang H; Zheng X; Zhang Y; Wang L; Li X
Brief Bioinform; 2020 Dec; 21(6):2153-2166. PubMed ID: 31792500
[TBL] [Abstract][Full Text] [Related]
14. N6-methyladenosine-related lncRNAs identified as potential biomarkers for predicting the overall survival of Asian gastric cancer patients.
Xu S; Chen W; Wang Y; Zhang Y; Xia R; Shen J; Gong X; Liang Y; Xu J; Tang H; Zhao T; Zhang Y; Chen T; Wang C
BMC Cancer; 2022 Jul; 22(1):721. PubMed ID: 35778697
[TBL] [Abstract][Full Text] [Related]
15. Systematic identification of lncRNA-based prognostic biomarkers for glioblastoma.
Li M; Long S; Hu J; Wang Z; Geng C; Ou S
Aging (Albany NY); 2019 Nov; 11(21):9405-9423. PubMed ID: 31692451
[TBL] [Abstract][Full Text] [Related]
16. Development and validation of prognostic markers in sarcomas base on a multi-omics analysis.
Song Y; Yang K; Sun T; Tang R
BMC Med Genomics; 2021 Jan; 14(1):31. PubMed ID: 33509178
[TBL] [Abstract][Full Text] [Related]
17. A Novel Model Based on Genomic Instability-Associated Long Non-Coding RNAs for Predicting Prognosis and Response to Immunotherapy in Patients With Lung Adenocarcinoma.
Tu G; Peng W; Cai Q; Zhao Z; Peng X; He B; Zhang P; Shi S; Wang X
Front Genet; 2021; 12():720013. PubMed ID: 34777461
[No Abstract] [Full Text] [Related]
18. Relationships of N6-Methyladenosine-Related Long Non-Coding RNAs With Tumor Immune Microenvironment and Clinical Prognosis in Lung Adenocarcinoma.
Zhao J; Lin X; Zhuang J; He F
Front Genet; 2021; 12():714697. PubMed ID: 34777460
[No Abstract] [Full Text] [Related]
19. Autophagy-related long non-coding RNA prognostic model predicts prognosis and survival of melanoma patients.
Qiu Y; Wang HT; Zheng XF; Huang X; Meng JZ; Huang JP; Wen ZP; Yao J
World J Clin Cases; 2022 Apr; 10(11):3334-3351. PubMed ID: 35611195
[TBL] [Abstract][Full Text] [Related]
20. Dysregulated ceRNA network modulated by copy number variation-driven lncRNAs in breast cancer: A comprehensive analysis.
Zhu X; Song J; Wang M; Wang X; Lv L
J Gene Med; 2023 Mar; 25(3):e3471. PubMed ID: 36525372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]